Optimize deals

Uncover and deliver on opportunities in the shifting deals environment

Now more than ever, navigating deals in the pharmaceutical and life sciences industry requires confident decision making to stay a step ahead of competitive forces and the ever-changing market dynamics. For those organizations that manage through the complexity inherent in deal making, the opportunities for value creation are compelling. 

We understand that deals are dynamic. We’ve worked across deals of many shapes and sizes and can deliver on the plan that we’ll define together. We help you to drive the growth that develops a more profitable future: not just for this deal, but across your business for years to come. Learn more about PwC’s US Deals practice.

 

Explore pharmaceutical and life sciences

Accelerate R&D Maintain financial trust and transparency Navigate risk and regulatory complexity Optimize global taxes Stimulate commercial innovation Strategy and transformation Strengthen operational efficiency

{{filterContent.facetedTitle}}

{{contentList.dataService.numberHits}} {{contentList.dataService.numberHits == 1 ? 'result' : 'results'}}
{{contentList.loadingText}}
{{item.videoDuration}}

{{item.title}}

{{item.text}}

Start adding items to your reading lists:
Sign in
or
Create your account
Save this item to:
This item has been saved to your reading list.
{{contentList.loadingText}}
{{contentList.loadMoreLabel}} {{contentList.viewAllLabel}}

Contact us

Glenn Hunzinger

Glenn Hunzinger

US Pharmaceutical and Life Sciences Leader, PwC US

Linkedin Follow Twitter Follow Email
Follow us
Audit and assurance Consulting Tax services Newsroom Alumni US offices Contact us

© 2017 - 2020 PwC. All rights reserved. PwC refers to the US member firm or one of its subsidiaries or affiliates, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.